Peanut Allergy
📧 Sign up to get email alerts when something new happens for Peanut Allergy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-06-12Clinical Trial Results: Study of Efficacy, Safety and Tolerability of Remibrutinib in Adult Participants With an Allergy to Peanuts [Phase 2]
Phase 2 trial assessing remibrutinib for peanut allergy in adults, reporting efficacy, safety, and tolerability.
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Study of ENP-501 in Peanut-Allergic and Non-Allergic Participants [Phase 1, Phase 2]
A Phase 1/2 study of ENP-501 in peanut-allergic and non-allergic participants is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Food-Specific and Component IgE Threshold Levels That Predict Food Allergy in People With Elevated Total Serum IgE Levels and Atopic Dermatitis [Phase 2]
Phase 2 study evaluating whether food-specific and component IgE thresholds can predict milk allergy or peanut allergy in people with elevat…
-
CLINICAL_TRIALS trial_result · 2026-04-16Clinical Trial Update: Basophil Activation Test (BAT) Sensitivity in Child Food Allergy [Phase 4]
A Phase 4 trial update reports on the sensitivity of the Basophil Activation Test in children with egg and peanut allergies; the study has b…
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: UKK-0018 as an Immunotherapeutic for Treatment of Peanut Allergies [Phase 1, Phase 2]
A phase 1/2 trial update indicates Ukko's UKK-0018 immunotherapy for peanut allergy and peanut-induced anaphylaxis is currently recruiting. …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: Food Oral Immunotherapy for Peanut Allergy
Clinical trial update on peanut oral immunotherapy for peanut allergy, sponsored by Massachusetts General Hospital; the study is currently a…
-
CLINICAL_TRIALS trial_result · 2026-03-30Clinical Trial Update: PK/PD Study of IN-001 Sublingual Spray in Healthy Adults [Phase 1]
Phase 1 PK/PD study of IN-001 Sublingual Spray in healthy adults is currently recruiting to characterize pharmacokinetics and pharmacodynami…
-
CLINICAL_TRIALS research · 2026-03-24Clinical Trial Update: Safety Study of Viaskin® Peanut Patch in Peanut-Allergic Children 1 Through 3 Years of Age (COMFORT Toddlers) [Phase 3]
Phase 3 safety study COMFORT Toddlers of the Viaskin Peanut Patch in peanut-allergic children ages 1 to 3 is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-03-18Clinical Trial Update: Peanut Sublingual Immunotherapy (SLIT)-Tablet for Treatment of Peanut Allergy [Phase 1, Phase 2]
This clinical trial update reports a Phase 1/2 study evaluating a peanut sublingual immunotherapy tablet for peanut allergy, sponsored by AL…
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: Phase I Trial to Evaluate VLP Peanut in Healthy and Peanut Allergic Subjects [Phase 1]
A Phase I trial evaluating a virus-like particle (VLP) peanut investigational therapy in healthy volunteers and peanut-allergic subjects, sp…
-
CLINICAL_TRIALS trial_result · 2026-03-09Clinical Trial Update: Pinpoint Trial: Prebiotics IN Peanut Oral ImmunoTherapy [Phase 1, Phase 2]
The Pinpoint Trial evaluating prebiotics in peanut oral immunotherapy for peanut allergy has completed Phase 1/Phase 2 with results posted.
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: Comparing Standard and Autoclaved Peanut Oral Immunotherapy in People With Peanut Allergy [Phase 2]
A Phase 2 clinical trial is comparing standard peanut oral immunotherapy with autoclaved peanut oral immunotherapy in people with peanut all…
-
EMA approval · 2026-02-12EMA Authorised: Palforzia (defatted powder of Arachis hypogaea L., semen (peanuts)) — Stallergenes
The European Medicines Agency authorised Palforzia for peanut hypersensitivity in the EU. The product is a peanut allergen immunotherapy dev…
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: Investigating Modified Protocols of Oral Immunotherapy to Validate Efficacy and Safety [NA]
A McGill-led clinical trial is testing modified oral immunotherapy protocols to evaluate efficacy and safety for peanut, cow's milk, and egg…
-
CLINICAL_TRIALS research · 2026-02-02Clinical Trial Update: A Long Term, Observational Follow-Up Study of Children and Young People Who Underwent an 18-Month Course of Oral Immunotherapy Treatment for Peanut, Egg or Milk Allergy (5-15 Years Post-Treatment)
A long-term observational follow-up study evaluating outcomes 5-15 years after completing an 18-month oral immunotherapy course for peanut, …
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: Safety and Efficacy Study of Viaskin Peanut in Peanut-allergic Children 4-7 Years of Age [Phase 3]
This is a Phase 3 trial update for Viaskin Peanut in peanut-allergic children aged 4-7. The study is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2026-01-15Clinical Trial Update: Expanded Access Protocol of Viaskin® Peanut (DBV712) in Peanut-allergic Children
This document provides an update on the expanded access protocol for Viaskin Peanut (DBV712) in peanut-allergic children. The protocol is cu…
-
CLINICAL_TRIALS research · 2025-12-30Clinical Trial Update: Study to Evaluate the Safety, Pharmacokinetic, and Pharmacodynamic Effects of MY006 in Healthy Volunteers and Patients With Peanut Allergy [Phase 1]
Mabylon AG's investigational therapy MY006 is in Phase 1 to evaluate safety, pharmacokinetics, and pharmacodynamics in healthy volunteers an…
-
CLINICAL_TRIALS trial_result · 2025-12-26Clinical Trial Update: Accidental Reactions in Peanut/Tree Nut Allergic Children
A clinical trial studying accidental reactions in peanut and tree nut allergic children has completed. The sponsor is University Hospital, L…
-
CLINICAL_TRIALS trial_result · 2025-12-08Clinical Trial Update: High and Low Dose Oral Peanut Immunotherapy - Comparison of Efficacy and Safety [NA]
This clinical trial compares high-dose versus low-dose oral peanut immunotherapy to assess efficacy and safety in individuals with peanut al…
-
CLINICAL_TRIALS research · 2025-12-02Clinical Trial Update: Understanding the Immune System's Role in Tree Nut and Peanut Allergies: Key Biomarkers for Diagnosis and Treatment Monitoring and Treatment Targets
This clinical trial update discusses immune biomarkers for diagnosing and monitoring peanut and tree nut allergies. It also identifies poten…
-
CLINICAL_TRIALS trial_result · 2025-11-14Clinical Trial Update: Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of IGNX001 [Phase 1]
This update reports the completion of a Phase 1 trial evaluating IGNX001 for peanut allergy, focusing on safety, tolerability, pharmacokinet…
-
CLINICAL_TRIALS trial_result · 2025-10-30Clinical Trial Update: Efficacy of Tezepelumab in Peanut Oral Immunotherapy [Phase 2]
Phase 2 trial evaluating tezepelumab for peanut oral immunotherapy is not yet recruiting.
-
CLINICAL_TRIALS research · 2025-10-15Clinical Trial Update: A Safety and Efficacy Study of PVX108 in Children and Adolescents With Peanut Allergy [Phase 2]
PVX108 is being studied in a Phase 2 safety and efficacy trial for peanut allergy in children and adolescents, with the study currently acti…
-
CLINICAL_TRIALS research · 2025-08-24Clinical Trial Update: Evaluating the Safety and Efficacy of Oral Encapsulated Microbiota Transplantation Therapy in Peanut Allergic Patients [Phase 2]
A Phase 2 clinical trial is assessing the safety and efficacy of an oral encapsulated microbiota transplantation therapy in peanut-allergic …